Eritema nodoso leproso en un paciente pediátrico
Palabras clave:
eritema nodoso leproso, reacción tipo II, lepra lepromatosaResumen
Se presenta el caso de una paciente de 8 años de edad que cúnsulta por un mes de evolución de lesiones infiltradas, eritematosas, en cara y extremidades, fiebre, síntomas constitucionales y artritis de codo derecho. La histopatología fue compatible con un eritema nodoso leproso.
Biografía del autor/a
Ana Francisca Ramírez Escobar, Universidad del Valle
RIII Dermatología, Universidad del Valle, Cali.
Luis Hernando Moreno M., Universidad del Valle
Docente Dermatología, Hospital Universitario del Valle, Cali.
Ricardo Rueda P., Universidad del Valle
Docente Dermatopatología, Hospital Universitario del Valle, Cali.
Roberto Jaramillo, Universidad del Valle
R/1I Patología, Universidad del Valle, Cali.
Luis Eduardo Bravo, Universidad del Valle
Docente Patología, Universidad del Valle, Cali.
Jairo Victoria Ch., Universidad del Valle
Docente Dermatología, Universidad del Valle, Cali.
Referencias bibliográficas
1. Rea TH, Modlin RL. Leprosy. En: Fitzpatrick' s. Dermatology in General Medicine, 1999:2306-2318.
2. Manandhar R, LeMaster J, Roche PW. Risk factors for erythema nodosum leprosum. lnt J Lepra Other Mycobact Dis 1999; 67:270-278.
3. Naafs B. Reactions in leprosy. Biology of the Mycobacteria, London, Academic Press 1989:359-403.
4. Rea TH, Levan NE. Lucio's phenomenon and diffuse non-nodular lepromatous leprosy. Arch Dermatol 1978, 114: 1023-1028.
https://doi.org/10.1001/archderm.114.7.1023
5. Hussain R, Lucas SB, Kifayet A, et al. Clinical and histological discrepancies in diagnosis of erythema nodosum leprosum reactions classified by assessment of acule phase proteins SAA and CRP. lnt J Lepr Other Mycobact Dis 1995; 63:222-230.
6. Moraes MO, Sarno EN, Almeida AS, et al. Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL). Scand J lmmunol 1999; 50:541-549.
https://doi.org/10.1046/j.1365-3083.1999.00622.x
7. Sreenivasan P, Misra RS, Wilfred D, et al. Lepromatous leprosy patients show T-helper 1-like cytokine profile with differential expression of interleukin-1 O during type 1 and 2 reactions. lmmunology 1998; 95:529-536
https://doi.org/10.1046/j.1365-2567.1998.00634.x
8. Sánchez P, Castillo F. lgG antibody subclasses, tumor necrosis factor and IFN-g levels in patients with type 11 lepra reaction on thalidomide treatment. lnt Arch Allergy lmmunol 1998; 116:60-66.
https://doi.org/10.1159/000023926
9. Job CK, Yoder L, Jacobson RR, et al. Skin pigmentation from clofazimine therapy in leprosy patients: a reappraisal. J Am Acad Dermatol 1990; 23:236-241.
https://doi.org/10.1016/0190-9622(90)70204-U
10. Calabresse L, Fleischer AB. Thalidomide: current and potential clinical applications. Am J Med 2000; 108:487-495.
https://doi.org/10.1016/S0002-9343(99)00408-8
2. Manandhar R, LeMaster J, Roche PW. Risk factors for erythema nodosum leprosum. lnt J Lepra Other Mycobact Dis 1999; 67:270-278.
3. Naafs B. Reactions in leprosy. Biology of the Mycobacteria, London, Academic Press 1989:359-403.
4. Rea TH, Levan NE. Lucio's phenomenon and diffuse non-nodular lepromatous leprosy. Arch Dermatol 1978, 114: 1023-1028.
https://doi.org/10.1001/archderm.114.7.1023
5. Hussain R, Lucas SB, Kifayet A, et al. Clinical and histological discrepancies in diagnosis of erythema nodosum leprosum reactions classified by assessment of acule phase proteins SAA and CRP. lnt J Lepr Other Mycobact Dis 1995; 63:222-230.
6. Moraes MO, Sarno EN, Almeida AS, et al. Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL). Scand J lmmunol 1999; 50:541-549.
https://doi.org/10.1046/j.1365-3083.1999.00622.x
7. Sreenivasan P, Misra RS, Wilfred D, et al. Lepromatous leprosy patients show T-helper 1-like cytokine profile with differential expression of interleukin-1 O during type 1 and 2 reactions. lmmunology 1998; 95:529-536
https://doi.org/10.1046/j.1365-2567.1998.00634.x
8. Sánchez P, Castillo F. lgG antibody subclasses, tumor necrosis factor and IFN-g levels in patients with type 11 lepra reaction on thalidomide treatment. lnt Arch Allergy lmmunol 1998; 116:60-66.
https://doi.org/10.1159/000023926
9. Job CK, Yoder L, Jacobson RR, et al. Skin pigmentation from clofazimine therapy in leprosy patients: a reappraisal. J Am Acad Dermatol 1990; 23:236-241.
https://doi.org/10.1016/0190-9622(90)70204-U
10. Calabresse L, Fleischer AB. Thalidomide: current and potential clinical applications. Am J Med 2000; 108:487-495.
https://doi.org/10.1016/S0002-9343(99)00408-8
Cómo citar
1.
Ramírez Escobar AF, Moreno M. LH, Rueda P. R, Jaramillo R, Bravo LE, Victoria Ch. J. Eritema nodoso leproso en un paciente pediátrico. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de febrero de 2002 [citado 11 de diciembre de 2023];10(1):703-6. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/622
Descargas
Los datos de descargas todavía no están disponibles.
Descargas
Publicado
2002-02-01
Cómo citar
1.
Ramírez Escobar AF, Moreno M. LH, Rueda P. R, Jaramillo R, Bravo LE, Victoria Ch. J. Eritema nodoso leproso en un paciente pediátrico. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 1 de febrero de 2002 [citado 11 de diciembre de 2023];10(1):703-6. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/622
Número
Sección
Sin sección en el original
